Sigyn Therapeutics (SIGY) Current Assets (2016 - 2025)
Sigyn Therapeutics' (SIGY) quarterly Current Assets came in at $85571.0 in Q3 2025, down 68.2% year-over-year from $269108.0 in Q3 2024, and up 4764.75% quarter-over-quarter from $1759.0 in Q2 2025.
Powered by 
Analysis
Sigyn Therapeutics (SIGY) Current Assets (2016 - 2025) Analysis & Trends
Sigyn Therapeutics has disclosed Current Assets across 10 years of filings, most recently posting $85571.0 for Q3 2025.
- In Q3 2025, Current Assets fell 68.2% year-over-year to $85571.0; the TTM figure through Sep 2025 stood at $85571.0 (down 68.2% YoY), while the FY2024 annual figure was $21244.0, down 82.01% from the prior year.
- Current Assets came in at $85571.0 for Q3 2025 at Sigyn Therapeutics, up from $1759.0 in the prior quarter.
- In the past five years, Current Assets ranged from a high of $1.7 million in Q2 2021 to a low of $1759.0 in Q2 2025.
- Average Current Assets over 5 years is $301854.3, with a median of $134428.0 recorded in 2024.
- Year-over-year, Current Assets surged 187.19% in 2023 and sank 98.8% in 2025.
- Over 5 years, Current Assets stood at $393031.0 in 2021, then slumped by 82.11% to $70298.0 in 2022, then jumped by 67.95% to $118063.0 in 2023, then plunged by 82.01% to $21244.0 in 2024, then surged by 302.8% to $85571.0 in 2025.
- Per Business Quant data, the three most recent Current Assets figures were $85571.0 in Q3 2025, $1759.0 in Q2 2025, and $68095.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.94 Bn | 175.34 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Intuitive Surgical | 127.83 Bn | 122.62 Bn | 1.96 Bn | 9.54 Bn |
| 3 | Medtronic | 116.96 Bn | 108.14 Bn | 6.34 Bn | 24.39 Bn |
| 4 | Stryker | 104.44 Bn | 100.97 Bn | 4.50 Bn | 14.42 Bn |
| 5 | Boston Scientific | 63.87 Bn | 63.33 Bn | 3.85 Bn | 7.97 Bn |
| 6 | Edwards Lifesciences | 49.91 Bn | 45.65 Bn | 1.35 Bn | 6.82 Bn |
| 7 | Alcon | 33.06 Bn | 31.60 Bn | 1.68 Bn | 6.62 Bn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | 4.09 Bn |
| 9 | Steris | 20.68 Bn | 20.20 Bn | 684.20 Mn | 2.45 Bn |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | 85,571.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 85,571.00 |
| Jun 30, 2025 | 1,759.00 |
| Mar 31, 2025 | 68,095.00 |
| Dec 31, 2024 | 21,244.00 |
| Sep 30, 2024 | 269,108.00 |
| Jun 30, 2024 | 146,376.00 |
| Mar 31, 2024 | 134,428.00 |
| Dec 31, 2023 | 118,063.00 |
| Sep 30, 2023 | 168,871.00 |
| Jun 30, 2023 | 128,795.00 |
| Mar 31, 2023 | 412,488.00 |
| Dec 31, 2022 | 70,298.00 |
| Sep 30, 2022 | 85,377.00 |
| Jun 30, 2022 | 104,997.00 |
| Mar 31, 2022 | 143,630.00 |
| Dec 31, 2021 | 393,031.00 |
| Sep 30, 2021 | 1.12 Mn |
| Jun 30, 2021 | 1.67 Mn |
| Mar 31, 2021 | 593,154.00 |
| Dec 31, 2020 | 670,449.00 |